ACETO Corporation Investor Presentation November 2, 2016

Size: px
Start display at page:

Download "ACETO Corporation Investor Presentation November 2, 2016"

Transcription

1 NASDAQ:ACET ACETO Corporation Investor Presentation November 2, 2016 Sourcing & Supplying Quality Products Worldwide

2 Disclosure This presentation contains forward-looking statements, as defined by the Private Securities Litigation Reform Act of 1995, that can be identified by words such as believes, expects, anticipates, plans, projects, seeks and similar expressions and involve numerous risks and uncertainties. The Company s actual results could differ materially from those anticipated or implied in such forward-looking statements as a result of certain factors, as set forth in the Company s filings with the Securities and Exchange Commission. 2

3 Company Overview Transforming Towards Pharmaceuticals Focus on niche products Consultative selling Highly skilled, technically trained sales force Human Health Pharma Ingredients Performance Chem. Partnership model Global reach Finished Dosage Form Generics Nutritionals: supply app. 250 popular dietary supplements Active Pharmaceutical Ingredients Pharmaceutical Intermediates Specialty Chemicals Agricultural Protection Products Int l technical network Regional managers in US, Europe & Asia SOURCING REGULATORY SUPPORT QUALITY ASSURANCE 3

4 Mix Shifting Toward Human Health Oriented Businesses Net Sales- 8% CAGR Gross Profit- 18% CAGR FY 2010 FY 2016 FY 2010 FY % 14% 39% 30% 29% 41% 45% 14% 41% 25% 20% 55% $346.6 Million $558.5 Million $54.2 Million (Gross Margin- 15.6%) $142.8 Million (Gross Margin- 25.6%) Date Dec. '10 May '12 Mar. '14 Sept. '14 Dec. '14 Feb. '15 Sept. '15 Sept. '15 Timeline of Transformation Toward Human Health Oriented Business Event Acquired Rising Pharmaceutical New logo and renamed business segments Acquired Pack Pharmaceuticals Acquired three ANDAs from Par utilizing softgel technology SIC code changed to Wholesale- Drugs, Proprietaries and Druggists Sundries GICS code changed to (Health Care - Health Care Distributors) Acquired 3 Opthalmic ANDAs from NEXUS Pharmaceuticals Acquired 3 ANDAs from ENDO International via FTC process 4

5 Investment Highlights Strategically positioned for growth through geographic expansion, new product offerings and bolt-on acquisitions Primary focus on human health products Rising Pharmaceuticals is a platform for higher margin finished dosage form generics Improving product mix drives margin expansion Asset-light business model generates strong free cash flow Strong financial position supports growth initiatives Experienced executive management team Track record of 50 consecutive years of dividend payments, providing return to shareholders 5

6 Human Health Product Groups Finished dosage form generic drugs (Rising Pharmaceuticals) 60+ commercial products 100+ pipeline products Nutritionals Nutraceutical ingredients Packaged dietary supplements Growth Strategy Expand portfolio of high margin finished dosage form generic products Globalize and expand nutraceutical ingredients 6

7 Rising Pharmaceuticals Platform for growth as developer and marketer with established generics brand Strong brand recognition of Rising label among pharmacists and pharmaceutical product buyers Long-standing commitment to quality, service, supply and integrity Strategically utilizes partnership model Product development programs ANDA acquisitions Paragraph IV product partnerships Authorized generic marketer Licensing opportunities on late stage product assets 7

8 Rising Drug Development Pipeline Product Development Biostudies Underway Filed with FDA Approved / Pending Launch Launched 3 ANDAs 8 ANDAs 46 ANDAs 7 Products 39 Products 100* Pipeline Projects *Does not include the 3 products on this chart launched in FY

9 Aging of Filed ANDAs 9

10 Value* of Filed ANDAs *Based on total market, including brand & generic where applicable, using August 2016 IMS sales data 10

11 Broad Based Nutritional Products Offered on Global Basis Supply approximately 250 popular dietary supplements: Amino Acids Quercetin Coenzyme Q10 Lactoferrin Chondroitin Sulfate Fish Oil/Omega 3 Vitamins EU 39% Fiscal 2016 Sales Asia 4% United States 57% 11

12 Human Health Customers (representative) 12

13 Pharmaceutical Ingredients Product Groups Active Pharmaceutical Ingredients (API s) - bulk ingredients which impart therapeutic value to the drug Pharmaceutical intermediates building block chemicals used in the manufacturing of API s Growth Strategy Focus on niche, small/mid-size products with a limited number of competitors Serve as second source for branded drugs and generics 13

14 Pharmaceutical Ingredients Customers (representative) 14

15 Performance Chemicals Product Groups Specialty Chemicals - for coatings, inks, plastics, food, electronics, agricultural intermediates & other industrial applications Agricultural Protection Products - fungicides, insecticides and sprout inhibitors Growth Strategy Globalization of product offering Creation of new product opportunities through new suppliers Developing new products for existing customers Continue to seek new generic Ag registrations 15

16 Performance Chemicals Customers (representative) 16

17 Value Proposition to Customers Core business competencies serve as sales and marketing drivers: Sourcing Regulatory Support Quality Assurance Relieves customer of logistical concerns; ensures that products meet regulatory requirements Highly skilled, technically trained business development/sales force: >270 employees worldwide Well versed in science, regulations, chemistry and assessing customer and marketing needs to develop opportunities Function as virtual manufacturing company Match customers with fully vetted suppliers 17

18 Worldwide Presence UNITED KINGDOM GERMANY NETHERLANDS JAPAN USA Corporate HQ New York CHINA PHILIPPINES SINGAPORE FRANCE INDIA 18

19 Global Sourcing China: Predominately source specialty chemicals, agricultural protection products and intermediates 26 local professionals India: Predominately source active ingredients and nutritionals 12 local professionals North America: Predominately source finished dosage form generics North America 22% 16% Europe Fiscal 2016 Other 6% Asia 56% 19

20 Support: Technical & Regulatory with emphasis on Quality Assurance KEY differentiator between Aceto and other distribution companies International Technical Network with regional managers in U.S., Europe and Asia International Regulatory Support Provides substantial global assistance as required Enables manufacturers to bring products to market in conformance with regulations that they might not otherwise accomplish on their own Worldwide Quality Assurance ensures that product quality meets both the customers specifications and intended use 20

21 Strong Financial Position Provides Financial Flexibility Financial position at September 30, 2016: Cash, cash equivalents and short-term investments of $75 million Convertible debt of $117 million Other bank debt of $3 million Working capital of $263 million Shareholders equity of $310 million Strong cash flow affords an expected $0.26 per share annual dividend rate 21

22 Strong Track Record of Growth ($ in millions) $600 $500 $400 $300 $200 $100 $0 $346.6 CAGR 8% Net Sales $412.4 $444.4 $547.0 $558.5 $499.7 $510.2 FY '10 FY '11 FY '12 FY '13 FY '14 FY '15 FY '16 $1.60 $1.40 $1.20 $1.00 $0.80 $0.60 $0.40 $0.20 $0.00 EPS (non-gaap) CAGR 23% $1.33 $1.22 $1.01 $0.78 $0.58 $0.44 $1.50 FY '10 FY '11 FY '12 FY '13 FY '14 FY '15 FY '16 22

23 Expanding EBITDA & EBITDA Margin (non-gaap) $80 EBITDA ($ in millions) $70 $60 $50 $40 $30 $20 $10 $0 FY '10 FY '11 FY '12 FY '13 FY '14 FY '15 FY '16 EBITDA EBITDA Margins EBITDA Margin 14.0% 12.0% 10.0% 8.0% 6.0% 4.0% 2.0% 0.0% 23

24 Investment Highlights Strategically positioned for growth through geographic expansion, new product offerings and bolt-on acquisitions Primary focus on human health products Rising Pharmaceuticals is a platform for higher margin finished dosage form generics Improving product mix drives margin expansion Asset-light business model generates strong free cash flow Strong financial position supports growth initiatives Experienced executive management team Track record of 50 consecutive years of dividend payments, providing return to shareholders 24

25 NASDAQ:ACET Global Leader in the Marketing and Distribution of Pharmaceutical Intermediates & Active Ingredients, Finished Dosage Form Generics, Nutraceutical Products, Agricultural Protection Products, and Specialty Chemicals For additional information please contact: Jody Burfening LHA Investor Relations rd Avenue, 17 th Fl. New York, NY Tel: Sourcing & Supplying Quality Products Worldwide 25

We add value as one company

We add value as one company Dr. Kurt Bock Chairman of the Board of Executive Directors Nomura Global Chemical Industry Leaders Conference Rome March 23, 2012 We add value as one company Forward-looking statements This presentation

More information

Ludwigshafen, February 25, 2014

Ludwigshafen, February 25, 2014 Ludwigshafen, February 25, 2014 Analyst Conference FY2013 Cautionary note regarding forward-looking statements This presentation may contain forward-looking statements that are subject to risks and uncertainties,

More information

Fourth Quarter 2015 Conference Call

Fourth Quarter 2015 Conference Call Fourth Quarter 2015 Conference Call E. Scott Santi, Chairman & CEO Michael M. Larsen, Senior Vice President & CFO Aaron H. Hoffman, Vice President, Investor Relations January 27, 2016 Forward Looking Statements

More information

FOSSIL GROUP, INC. REPORTS THIRD QUARTER 2014 RESULTS. Third Quarter Net Sales Increase 10% to $894 Million; Diluted EPS Increases 24% to $1.

FOSSIL GROUP, INC. REPORTS THIRD QUARTER 2014 RESULTS. Third Quarter Net Sales Increase 10% to $894 Million; Diluted EPS Increases 24% to $1. FOSSIL GROUP, INC. REPORTS THIRD QUARTER RESULTS Third Quarter Net Sales Increase 10% to $894 Million; Diluted EPS Increases 24% to $1.96 Updates Full Year Guidance and Provides Fourth Quarter Guidance

More information

FOSSIL GROUP, INC. REPORTS FOURTH QUARTER AND FISCAL YEAR 2014 RESULTS; Fourth Quarter Net Sales of $1.065 Billion; Diluted EPS Increases 12% to $3.

FOSSIL GROUP, INC. REPORTS FOURTH QUARTER AND FISCAL YEAR 2014 RESULTS; Fourth Quarter Net Sales of $1.065 Billion; Diluted EPS Increases 12% to $3. FOSSIL GROUP, INC. REPORTS FOURTH QUARTER AND FISCAL YEAR 2014 RESULTS; Fourth Quarter Net Sales of $1.065 Billion; Diluted EPS Increases 12% to $3.00 Fiscal Year 2014 Net Sales Increase 8% to $3.510 Billion;

More information

Health Care Worldwide

Health Care Worldwide Health Care Worldwide Goldman Sachs - Leveraged Finance Healthcare Conference March 4, 2014 New York Goldman Sachs Leveraged Finance Conference, Fresenius SE & Co. KGaA Copyright, March 4, 2014 Page 1

More information

Credit Suisse Global Health Care Conference. March 5, 2013

Credit Suisse Global Health Care Conference. March 5, 2013 Credit Suisse Global Health Care Conference March 5, 2013 Safe Harbor Statement This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results

More information

Dr. Reddy s Q3 and 9M FY16 Financial Results

Dr. Reddy s Q3 and 9M FY16 Financial Results Press Release DR. REDDY'S LABORATORIES LTD. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500034. Telangana, India. INVESTOR RELATIONS KEDAR UPADHYE kedaru@drreddys.com (Ph: +91-40-66834297) CONTACT

More information

Health Care Worldwide

Health Care Worldwide Health Care Worldwide Credit Suisse Global Credit Products Conference September 18, 2014 Miami Credit Suisse Global Credit Products Conference, September 18, 2014 Copyright Page 1 Safe Harbor Statement

More information

Commerzbank German Investment Seminar. 9 January 2012

Commerzbank German Investment Seminar. 9 January 2012 Commerzbank German Investment Seminar 9 January 2012 Disclaimer This presentation may contain forward-looking statements based on current assumptions and forecasts made by Brenntag AG and other information

More information

Challenging quarter for Mobile Devices. Daily order rates improving. Free Cash Flow > Net Income. FCT acquisition. Page 3

Challenging quarter for Mobile Devices. Daily order rates improving. Free Cash Flow > Net Income. FCT acquisition. Page 3 August 7, 2013 Page 1 Statements in this release that are not historical are forward-looking and are subject to various risks and uncertainties that could cause actual results to vary materially from those

More information

A Leading Global Health Care Group

A Leading Global Health Care Group A Leading Global Health Care Group Commerzbank German Investment Seminar January 11/12, 2016 For detailed financial information please see our annual/quarterly reports and/or conference call materials

More information

J.P. MORGAN HIGH YIELD & LEVERAGED FINANCE CONFERENCE FEBRUARY 24, 2015

J.P. MORGAN HIGH YIELD & LEVERAGED FINANCE CONFERENCE FEBRUARY 24, 2015 J.P. MORGAN HIGH YIELD & LEVERAGED FINANCE CONFERENCE FEBRUARY 24, 2015 DISCLAIMER This presentation contains, in addition to historical information, certain forward-looking statements within the meaning

More information

Earnings Webcast & Conference Call

Earnings Webcast & Conference Call November 5, 2015 Earnings Webcast & Conference Call First Quarter FY 2016 2014 1 Forward-Looking Statements This presentation and other written or oral statements made from time to time by representatives

More information

Health Care Worldwide. Citi - European Credit Conference September 24, 2015 - London

Health Care Worldwide. Citi - European Credit Conference September 24, 2015 - London Health Care Worldwide Citi - European Credit Conference September 24, 2015 - London Safe Harbor Statement This presentation contains forward-looking statements that are subject to various risks and uncertainties.

More information

IMCD reports strong results for 2014

IMCD reports strong results for 2014 IMCD reports strong results for 2014 Rotterdam, The Netherlands 11 March 2015 - IMCD N.V. ( IMCD or Company ), a leading international speciality chemicals-focused distributor, today announces the 2014

More information

Health Care Worldwide

Health Care Worldwide Health Care Worldwide Barclays European High Yield and Leveraged Finance Conference October 30, 2014 London Barclays European High Yield and Leveraged Finance Conference, October 30, 2014 Copyright Page

More information

Stericycle, Inc. Q NASDAQ: SRCL

Stericycle, Inc. Q NASDAQ: SRCL Stericycle, Inc. Q1 2014 NASDAQ: SRCL Forward - Looking Statements This presentation may contain forward-looking statements that involve a number of risks and uncertainties and our actual results could

More information

Investor Presentation Q3 2014

Investor Presentation Q3 2014 Investor Presentation Q3 2014 Disclaimers Related to forward-looking statements This presentation may contain forward-looking statements that involve risks, uncertainties and other factors concerning,

More information

ITW Conference Call Third Quarter 2013

ITW Conference Call Third Quarter 2013 ITW Conference Call Third Quarter 2013 October 22, 2013 SOLID GROWTH. STRONG RETURNS. BEST-IN-CLASS OPERATOR. Forward-Looking Statements Safe Harbor Statement This conference call contains forward-looking

More information

ALBEMARLE 2008 INVESTOR CONFERENCE. Goldman Sachs Basic Materials Conference Mark C. Rohr, President & CEO New York, NY, May 21, 2008

ALBEMARLE 2008 INVESTOR CONFERENCE. Goldman Sachs Basic Materials Conference Mark C. Rohr, President & CEO New York, NY, May 21, 2008 Goldman Sachs Basic Materials Conference Mark C. Rohr, President & CEO New York, NY, May 21, 2008 1 Forward Looking Statements Portions of this presentation constitute forward-looking statements within

More information

PRESS RELEASE Noida, Tuesday, February 9, 2016 Jubilant Life Sciences Ltd. 1A, Sector 16A, Noida 201301, India Tel.: +91 120 4361000 http://www.jubl.com JUBILANT LIFE SCIENCES Q3 & 9M FY2016 RESULTS JUBILANT

More information

UBS Staff Agencies and Support Services Conference. 14 September 2011

UBS Staff Agencies and Support Services Conference. 14 September 2011 UBS Staff Agencies and Support Services Conference 14 September 2011 Disclaimer This presentation may contain forward-looking statements based on current assumptions and forecasts made by Brenntag AG and

More information

Intel Reports Second-Quarter Results

Intel Reports Second-Quarter Results Intel Corporation 2200 Mission College Blvd. Santa Clara, CA 95054-1549 CONTACTS: Mark Henninger Amy Kircos Investor Relations Media Relations 408-653-9944 480-552-8803 mark.h.henninger@intel.com amy.kircos@intel.com

More information

A Leading Global Health Care Group

A Leading Global Health Care Group A Leading Global Health Care Group Credit Suisse Global Health Care Conference, March 4, 2015 For detailed financial information please see our annual/quarterly reports and/or conference call materials

More information

Full year results. March 2012

Full year results. March 2012 2 0 1 1 Full year results March 2012 1 DISCLAIMER Safe Harbour Statement This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private Securities Litigation

More information

SOUTHWEST IDEAS INVESTOR CONFERENCE. November 20, 2014

SOUTHWEST IDEAS INVESTOR CONFERENCE. November 20, 2014 SOUTHWEST IDEAS INVESTOR CONFERENCE November 20, 2014 Forward-Looking Statements Some of the statements in this presentation constitute forward-looking statements about John B. Sanfilippo & Son, Inc. Such

More information

Raymond James' 31st Annual Institutional Investors Conference

Raymond James' 31st Annual Institutional Investors Conference Raymond James' 31st Annual Institutional Investors Conference Philip M. Pead, President and Chief Executive Officer Chris E. Perkins, Executive Vice President and Chief Financial Officer 0 Disclosure Statements

More information

Tim Howkins, CEO. Steve Clutton, Finance Director

Tim Howkins, CEO. Steve Clutton, Finance Director Tim Howkins, CEO Steve Clutton, Finance Director Highlights Revenue Revenue up 36% Earnings per share up 33% All parts of business contributed to growth Benefits of increased IT spend Proposed final dividend

More information

Credit Suisse - Global Health Care Conference. March 1, 2012

Credit Suisse - Global Health Care Conference. March 1, 2012 Credit Suisse - Global Health Care Conference March 1, 2012 Safe Harbor Statement This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results

More information

Q1 Fiscal Year 2016 Earnings Conference Call

Q1 Fiscal Year 2016 Earnings Conference Call NASDAQ: CMCO Q1 Fiscal Year 2016 Earnings Conference Call July 31, 2015 Timothy T. Tevens President & Chief Executive Officer Gregory P. Rustowicz Vice President - Finance & Chief Financial Officer 2015

More information

Sanford C. Bernstein Strategic Decisions Conference. May 2014. Tom Lynch Chairman and Chief Executive Officer

Sanford C. Bernstein Strategic Decisions Conference. May 2014. Tom Lynch Chairman and Chief Executive Officer Sanford C. Bernstein Strategic Decisions Conference May 2014 Tom Lynch Chairman and Chief Executive Officer FORWARD-LOOKING STATEMENTS AND NON-GAAP MEASURES Forward-Looking Statements -- This presentation

More information

Software AG Results 1 st Quarter 2015 (IFRS, unaudited)

Software AG Results 1 st Quarter 2015 (IFRS, unaudited) Software AG Results 1 st Quarter (IFRS, unaudited) April 29, 1 Safe Harbor This presentation includes forward-looking statements based on the beliefs of Software AG management. Such statements reflect

More information

DATA GROUP LTD. ANNOUNCES FIRST QUARTER RESULTS FOR 2014

DATA GROUP LTD. ANNOUNCES FIRST QUARTER RESULTS FOR 2014 For Immediate Release DATA GROUP LTD. ANNOUNCES FIRST QUARTER RESULTS FOR 2014 HIGHLIGHTS Q1 2014 First quarter 2014 ( Q1 ) Revenues of 77.9 million, Q1 Gross Profit of 18.8 million and Q1 Net Income of

More information

HILLENBRAND A GLOBAL DIVERSIFIED INDUSTRIAL COMPANY

HILLENBRAND A GLOBAL DIVERSIFIED INDUSTRIAL COMPANY HILLENBRAND A GLOBAL DIVERSIFIED INDUSTRIAL COMPANY PURSUING GROWTH BUILDING VALUE Hillenbrand Participants Joe Raver President and Chief Executive Officer Kristina Cerniglia Senior Vice President and

More information

China Pharma Holdings, Inc. Reports Second Quarter 2010 Financial Results

China Pharma Holdings, Inc. Reports Second Quarter 2010 Financial Results China Pharma Holdings, Inc. Reports Second Quarter 2010 Financial Results HAIKOU CITY, China, August 10, 2010 China Pharma Holdings, Inc. (NYSE AMEX: CPHI) ( China Pharma or the Company ), a leading fully

More information

Driving Shareholder Value

Driving Shareholder Value Driving Shareholder Value Business Model and Capital Allocation Strategy Wolfgang Nickl CFO, Western Digital September 13, 2012 SAFE HARBOR Forward-Looking Statements This presentation contains forward-looking

More information

N E W S R E L E A S E

N E W S R E L E A S E N E W S R E L E A S E Foot Locker, Inc. 112 West 34 th Street, New York, NY 10120 Contact: John A. Maurer Vice President, Treasurer and Investor Relations Foot Locker, Inc. (212) 720-4092 FOOT LOCKER,

More information

1 st QUARTER 2015 EARNINGS RESULTS Fran Shammo Chief Financial Officer

1 st QUARTER 2015 EARNINGS RESULTS Fran Shammo Chief Financial Officer VlpHU09DSUQyMDE1UTE= VlpHU09DSUQyMDE1UTE= 1 st QUARTER 2015 EARNINGS RESULTS Fran Shammo Chief Financial Officer April 21, 2015 Safe Harbor Statement NOTE: In this presentation we have made forward-looking

More information

Ipsen Jefferies Healthcare Conference

Ipsen Jefferies Healthcare Conference Ipsen Jefferies Healthcare Conference November 2015 IPSEN pour nom de la société - 07/04/2011 / page 1 Disclaimer This presentation includes only summary information and does not purport to be comprehensive.

More information

Dresdner Kleinwort German Investment Seminar. January 14-16, 2008

Dresdner Kleinwort German Investment Seminar. January 14-16, 2008 Dresdner Kleinwort German Investment Seminar January 14-16, 2008 Safe Harbor Statement This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future

More information

The Future of Consumer Health Care

The Future of Consumer Health Care The Future of Consumer Health Care Coming Together To Lead The Consumer Health Care Industry 2 Creating a New Business Model in Consumer Health Care 3 Serve More Consumers In More Parts of the World, More

More information

A Leading Global Health Care Group

A Leading Global Health Care Group A Leading Global Health Care Group JP Morgan Milan Investor Forum October 1, 2015 For detailed financial information please see our annual/quarterly reports and/or conference call materials on www.fresenius.com/ir.

More information

Cegedim Half-year results 2009 September 2009

Cegedim Half-year results 2009 September 2009 Cegedim Half-year results 2009 September 2009 1 Cegedim : Healthcare - its primary market Cegedim Founded in 1969 by Jean-Claude Labrune Jean-Claude Labrune family hold 67 % of Cegedim through FCB 849

More information

Superior Plus Corp. Annual General Meeting April 28, 2016 TSX: SPB

Superior Plus Corp. Annual General Meeting April 28, 2016 TSX: SPB Superior Plus Corp. Annual General Meeting April 28, 2016 TSX: SPB www.superiorplus.com Forward-Looking Statements and Information This presentation is for information purposes only and is not intended

More information

FISCAL Q3 2016 SUPPLEMENTAL FINANCIAL INFORMATION

FISCAL Q3 2016 SUPPLEMENTAL FINANCIAL INFORMATION FISCAL Q3 2016 SUPPLEMENTAL FINANCIAL INFORMATION April 29, 2016 Safe Harbor Statement This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933

More information

FY2010 Results Presentation. 23 March 2011

FY2010 Results Presentation. 23 March 2011 FY2010 Results Presentation 23 March 2011 Disclaimer This document is of a purely informative nature and does not constitute an offer to sell, exchange or buy, or the solicitation of an offer to buy, securities

More information

RECIPHARM TAKES NEXT STEP TOWARDS GLOBAL LEADERSHIP 18 th April, 2016 Thomas Eldered, Jean-François Hilaire

RECIPHARM TAKES NEXT STEP TOWARDS GLOBAL LEADERSHIP 18 th April, 2016 Thomas Eldered, Jean-François Hilaire RECIPHARM TAKES NEXT STEP TOWARDS GLOBAL LEADERSHIP 18 th April, 2016 Thomas Eldered, Jean-François Hilaire 1 RECIPHARM TAKES NEXT STEP TOWARDS GLOBAL LEADERSHIP Another step change in reach and scale

More information

FISCAL Q SUPPLEMENTAL FINANCIAL INFORMATION

FISCAL Q SUPPLEMENTAL FINANCIAL INFORMATION FISCAL Q2 2016 SUPPLEMENTAL FINANCIAL INFORMATION Safe Harbor Statement This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E

More information

Intel Reports Fourth-Quarter and Annual Results

Intel Reports Fourth-Quarter and Annual Results Intel Corporation 2200 Mission College Blvd. P.O. Box 58119 Santa Clara, CA 95052-8119 CONTACTS: Reuben Gallegos Amy Kircos Investor Relations Media Relations 408-765-5374 480-552-8803 reuben.m.gallegos@intel.com

More information

BlackBerry Reports 2015 Fiscal First Quarter GAAP Profitability

BlackBerry Reports 2015 Fiscal First Quarter GAAP Profitability NEWS RELEASE FOR IMMEDIATE RELEASE June 19, BlackBerry Reports 2015 Fiscal First Quarter GAAP Profitability Waterloo, ON BlackBerry Limited (NASDAQ: BBRY; TSX: BB), a global leader in mobile communications,

More information

For personal use only GALE PACIFIC LIMITED

For personal use only GALE PACIFIC LIMITED GALE PACIFIC LIMITED RESULTS FOR YEAR ENDED 30 JUNE 2013 FY13 Review FY13 FY12 FY11 A$M S A$M S % Variance A$M S Sales 120.0 110.5 9% 95.6 EBITDA 18.0 18.0 0% 15.8 EBIT 12.9 12.5 4% 9.9 NPAT 9.1 8.5 7%

More information

Speech of the Board of Management. General Shareholders Meeting, 9 June 2015

Speech of the Board of Management. General Shareholders Meeting, 9 June 2015 Speech of the Board of Management General Shareholders Meeting, 9 June 2015 AGENDA Overview of the financial year Steven Holland, CEO Financial figures 2014 Georg Müller, CFO ConnectingChemistry Steven

More information

CIGNA CORPORATION INVESTOR PRESENTATION. November 6, 2015. 2015 Cigna

CIGNA CORPORATION INVESTOR PRESENTATION. November 6, 2015. 2015 Cigna CIGNA CORPORATION INVESTOR PRESENTATION November 6, 2015 1 Forward looking statements and non-gaap measures CAUTIONARY STATEMENT FOR PURPOSES OF THE SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION

More information

King Reports First Quarter 2014 Results

King Reports First Quarter 2014 Results King Reports First Quarter 2014 Results Generates record quarterly mobile gross bookings of $480 million in Q1-14 Adjusted EBITDA more than triples year over year to $249 million in Q1-14 Extends reach

More information

Adoption of Business Net Income

Adoption of Business Net Income Adoption of Business Net Income 1 Forward Looking Statements This presentation contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking

More information

Investor and analyst factsheet

Investor and analyst factsheet Investor and analyst factsheet 2015 2014 1 Variation 4Q 15 4Q 14 1 Variation in m in m in m in m Sales 7,683 5,952 +29.1% 1,760 1,431 +23.0% Prices (4.7)% (8.5)% Volumes +0.2% +2.1% FX +7.8% +5.1% Portfolio

More information

Comprehensive Medical Waste and Unused Medication Management Solutions Provider NASDAQ: SMED

Comprehensive Medical Waste and Unused Medication Management Solutions Provider NASDAQ: SMED Comprehensive Medical Waste and Unused Medication Management Solutions Provider NASDAQ: SMED INVESTOR PRESENTATION NOVEMBER Safe Harbor These slides contain (and the accompanying oral discussion will contain)

More information

2002 Salomon Smith Barney Healthcare Conference. October 29, 2002

2002 Salomon Smith Barney Healthcare Conference. October 29, 2002 2002 Salomon Smith Barney Healthcare Conference October 29, 2002 John Hammergren Chairman and Chief Executive Officer Safe Harbor Clause Some of the information in this presentation may constitute forward-looking

More information

Contacts: Media: Margaret Kirch Cohen, +1 312-696-6383 or margaret.cohen@morningstar.com Investors may submit questions to investors@morningstar.com.

Contacts: Media: Margaret Kirch Cohen, +1 312-696-6383 or margaret.cohen@morningstar.com Investors may submit questions to investors@morningstar.com. Contacts: Media: Margaret Kirch Cohen, +1 312-696-6383 or margaret.cohen@morningstar.com Investors may submit questions to investors@morningstar.com. FOR IMMEDIATE RELEASE Morningstar, Inc. Reports First-Quarter

More information

Earnings Release Q2 FY 2015 January 1 to March 31, 2015

Earnings Release Q2 FY 2015 January 1 to March 31, 2015 Munich, Germany, May 7, 2015 Earnings Release FY 2015 January 1 to March 31, 2015 Portfolio gains drive income»for business volume, we performed well in our markets. The profitability of our Industrial

More information

ABENGOA. 2014: Financial Review. Barbara Zubiria. 8th Annual Analyst and Investor Day. EVP, Capital Markets & IR

ABENGOA. 2014: Financial Review. Barbara Zubiria. 8th Annual Analyst and Investor Day. EVP, Capital Markets & IR Innovative Technology Solutions for Sustainability ABENGOA 2014: Financial Review Barbara Zubiria EVP, Capital Markets & IR 8th Annual Analyst and Investor Day April 3 & 4, 2014 Forward-looking Statement

More information

Savvis Investor Update

Savvis Investor Update Savvis Investor Update Investor Relations, Fourth Quarter 2010 Review SEC Filings This document may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act

More information

Fiscal Q Supplemental Financial Information

Fiscal Q Supplemental Financial Information Supplemental Financial Information Fiscal Q4 2015 (quarter ended July 3, 2015) July 31, 2015 Fiscal Q1 2016 Supplemental Financial Information October 30, 2015 1 Safe Harbor Statement This document contains

More information

Harley-Davidson, Inc.- Financial and Strategic Analysis Review

Harley-Davidson, Inc.- Financial and Strategic Analysis Review Harley-Davidson, Inc. - Financial and Strategic Analysis Review Publication Date: Oct-2015 Company Snapshot Key Information Harley-Davidson, Inc., Key Information Web Address www.harley-davidson.com Financial

More information

9m RESULTS OCTOBER Harald Wilhelm I Chief Financial Officer

9m RESULTS OCTOBER Harald Wilhelm I Chief Financial Officer 1 9m RESULTS 2015 30 OCTOBER 2015 Harald Wilhelm I Chief Financial Officer SAFE HARBOUR STATEMENT 2 Disclaimer This presentation includes forward-looking statements. Words such as anticipates, believes,

More information

Oceaneering Reports First Quarter 2016 Results

Oceaneering Reports First Quarter 2016 Results PRESS RELEASE Oceaneering Reports First Quarter 2016 Results April 25, 2016 Houston, Texas Oceaneering International, Inc. ( Oceaneering or the Company ) (NYSE:OII) today reported net income of $25.1 million,

More information

Mitel. Powering connections

Mitel. Powering connections Mitel Powering connections TD Securities - Technology Care Investor Conference November 19, 2014 Safe Harbor Statement Forward Looking Statements Some of the statements in this presentation are forward-looking

More information

U.S. Bancorp Investor Day. Payment Services. Pamela Joseph Vice Chairman. September 12, 2013

U.S. Bancorp Investor Day. Payment Services. Pamela Joseph Vice Chairman. September 12, 2013 U.S. Bancorp Investor Day Payment Services Pamela Joseph Vice Chairman September 12, 2013 # Forward-looking Statements and Additional Information The following information appears in accordance with the

More information

First Quarter Fiscal 2010 Results Presentation

First Quarter Fiscal 2010 Results Presentation First Quarter Fiscal 2010 Results Presentation March 2, 2010 Safe Harbor Statement This announcement contains forward-looking statements. These statements are made under the safe harbor provisions of the

More information

Novelis Q3 Fiscal Year 2016 Earnings Conference Call

Novelis Q3 Fiscal Year 2016 Earnings Conference Call Novelis Q3 Fiscal Year 2016 Earnings Conference Call February 9, 2016 Steve Fisher President and Chief Executive Officer Steve Pohl Vice President and Interim Chief Financial Officer 1 Safe Harbor Statement

More information

FOURTH QUARTER NET INCOME INCREASES 12% TO A RECORD $5.32 BILLION FOURTH QUARTER EPS OF $1.02, UP 12% REVENUES INCREASE 9% TO $21.

FOURTH QUARTER NET INCOME INCREASES 12% TO A RECORD $5.32 BILLION FOURTH QUARTER EPS OF $1.02, UP 12% REVENUES INCREASE 9% TO $21. FOURTH QUARTER NET INCOME INCREASES 12% TO A RECORD $5.32 BILLION FOURTH QUARTER EPS OF $1.02, UP 12% REVENUES INCREASE 9% TO $21.9 BILLION CITIGROUP 2004 NET INCOME OF $17.0 BILLION, EPS OF $3.26 REVENUES

More information

Ferrari posted a record Q3 2015 performance

Ferrari posted a record Q3 2015 performance Ferrari posted a record Q3 2015 performance Shipments were 1,949 units, up 21% Net revenues were up 9% (3% at constant currencies) to Euro 723 million EBIT reached Euro 141 million, 610bps margin increase

More information

Orbitz Worldwide, Inc.

Orbitz Worldwide, Inc. Orbitz Worldwide, Inc. Q4 2013 Investor Presentation All information provided within is as of February 13 th, 2014 Disclaimers Related to forward-looking statements This presentation may contain forward-looking

More information

Midwest Investment Conference

Midwest Investment Conference June 22 2016 Midwest Investment Conference Lee D. Rudow President and CEO Michael J. Tschiderer Chief Financial Officer 1 Safe Harbor Statement This presentation contains forward looking statements within

More information

2012 Southwest IDEAS Investor Conference

2012 Southwest IDEAS Investor Conference 2012 Southwest IDEAS Investor Conference November 14, 2012 This presentation contains statements which constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform

More information

Pfizer Emerging Markets. Jean-Michel Halfon President and General Manager May 26, 2010

Pfizer Emerging Markets. Jean-Michel Halfon President and General Manager May 26, 2010 Pfizer Emerging Markets Jean-Michel Halfon President and General Manager May 26, 2010 Forward-Looking Statements and Non-GAAP Financial Information Our discussions during this presentation will include

More information

DPP - DSM in motion: driving focused growth DSM and JLL create leading pharma services company in US$ 2.6bn transaction 19 November 2013.

DPP - DSM in motion: driving focused growth DSM and JLL create leading pharma services company in US$ 2.6bn transaction 19 November 2013. DPP - DSM in motion: driving focused growth DSM and JLL create leading pharma services company in US$ 2.6bn transaction 19 November 2013 Page Safe harbor statement This presentation may contain forward-looking

More information

STRATEGY UPDATE 2 MARCH 2016

STRATEGY UPDATE 2 MARCH 2016 STRATEGY UPDATE 2 MARCH 2016 Portfolio Focus on Attractive Growth and Margin Opportunities André Lacroix, CEO Intertek Group plc, is today announcing a strategic update outlining the Group s plan to deliver

More information

Investor Presentation. April 2014

Investor Presentation. April 2014 Investor Presentation April 2014 Safe Harbor Statement This document includes supplemental financial measures that are or may be non-gaap financial measures. These supplemental financial measures should

More information

Commerzbank German Investment Seminar. January 14 15, 2013

Commerzbank German Investment Seminar. January 14 15, 2013 Commerzbank German Investment Seminar January 14 15, 2013 Safe Harbor Statement This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results

More information

650-527-5152 650-527-6273 SYMANTEC REPORTS FIRST QUARTER FISCAL YEAR 2016 RESULTS

650-527-5152 650-527-6273 SYMANTEC REPORTS FIRST QUARTER FISCAL YEAR 2016 RESULTS FOR IMMEDIATE RELEASE MEDIA CONTACT: INVESTOR CONTACT: Kristen Batch Sean Hazlett Symantec Corp. Symantec Corp. 650-527-5152 650-527-6273 kristen_batch@symantec.com sean_hazlett@symantec.com SYMANTEC REPORTS

More information

A LEADING GLOBAL HEALTH CARE GROUP. Frankfurt Stock Exchange (DAX30): FRE US ADR program (OTC): FSNUY wwww.fresenius.com/investors

A LEADING GLOBAL HEALTH CARE GROUP. Frankfurt Stock Exchange (DAX30): FRE US ADR program (OTC): FSNUY wwww.fresenius.com/investors A LEADING GLOBAL HEALTH CARE GROUP Frankfurt Stock Exchange (DAX30): FRE US ADR program (OTC): FSNUY wwww.fresenius.com/investors SAFE HARBOR STATEMENT This presentation contains forward-looking statements

More information

Financial Results. siemens.com

Financial Results. siemens.com s Financial Results Fourth Quarter and Fiscal 2015 siemens.com Key figures (in millions of, except where otherwise stated) Volume Q4 % Change Fiscal Year % Change FY 2015 FY 2014 Actual Comp. 1 2015 2014

More information

Fresenius Kabi Creating a Global Leader in I.V. Generic Drugs. Conference Call, July 7, 2008

Fresenius Kabi Creating a Global Leader in I.V. Generic Drugs. Conference Call, July 7, 2008 Fresenius Kabi Creating a Global Leader in I.V. Generic Drugs Conference Call, July 7, 2008 Disclaimer THIS PRESENTATION IS FOR INFORMATION PURPOSES ONLY AND MAY NOT BE FURTHER DISTRIBUTED OR PASSED ON

More information

Verifone Reports Results for the Second Quarter of Fiscal 2016

Verifone Reports Results for the Second Quarter of Fiscal 2016 Verifone Reports Results for the Second Quarter of Fiscal 2016 SAN JOSE, Calif. (BUSINESS WIRE) Verifone (NYSE: PAY), a world leader in payments and commerce solutions, today announced financial results

More information

Accenture Reports Strong Third-Quarter Fiscal 2016 Results. -- Revenues increase 9% in U.S. dollars and 10% in local currency to $8.

Accenture Reports Strong Third-Quarter Fiscal 2016 Results. -- Revenues increase 9% in U.S. dollars and 10% in local currency to $8. Accenture Reports Strong Third-Quarter Fiscal 2016 Results -- Revenues increase 9% in U.S. dollars and 10% in local currency to $8.4 billion -- -- EPS are $1.41, compared with $1.24; up 8% from adjusted

More information

2015 HALF YEAR RESULTS

2015 HALF YEAR RESULTS 19 AUGUST 2015 Delivering better nutrition for every step of life s journey CAUTIONARY STATEMENT This presentation contains forward-looking statements. These statements have been made by the Directors

More information

Acquisition of SAIT Communications. 28 July 2015

Acquisition of SAIT Communications. 28 July 2015 Acquisition of SAIT Communications 28 July 2015 Conference call details SpeedCast acquires SAIT Communications The company has scheduled a conference call as follows: Time: 11.00am (Sydney time), 28 th

More information

Luxottica s net income from continuing operations for fiscal year 2006 rises by 100 million or by 30% Cash dividend for FY 2006 to increase by 45%

Luxottica s net income from continuing operations for fiscal year 2006 rises by 100 million or by 30% Cash dividend for FY 2006 to increase by 45% Luxottica s net income from continuing operations for fiscal year 2006 rises by 100 million or by 30% Cash dividend for FY 2006 to increase by 45% Milan, Italy March 5, 2007 - Luxottica Group S.p.A. (NYSE:

More information

Certain statements in this presentation constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of

Certain statements in this presentation constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of November 2015 1 Forward Looking Statements Certain statements in this presentation constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words

More information

Enhancing Value With Financial & Operational Excellence

Enhancing Value With Financial & Operational Excellence Enhancing Value With Financial & Operational Excellence Robert Hombach CFO & COO Enhancing Value With Financial & Operational Excellence Growing Sales & Earnings Generating value in attractive markets

More information

A LEADING GLOBAL HEALTHCARE COMPANY

A LEADING GLOBAL HEALTHCARE COMPANY A LEADING GLOBAL HEALTHCARE COMPANY Roadshow Boston March 2, 2016 Frankfurt stock exchange (DAX30): FRE US ADR program (OTC): FSNUY www.fresenius.com/investors SAFE HARBOR STATEMENT This presentation contains

More information

Trxade Group, Inc. (TCQB: TRXD): Record Revenues in Q3

Trxade Group, Inc. (TCQB: TRXD): Record Revenues in Q3 Siddharth Rajeev, B.Tech, MBA, CFA Analyst November 5, 2015 Trxade Group, Inc. (TCQB: TRXD): Record Revenues in Q3 Sector/Industry: E-commerce Market Data (as of November 5, 2015) Current Price $1.15 Fair

More information

Presented at: Jefferies 2015 Global Healthcare Conference

Presented at: Jefferies 2015 Global Healthcare Conference Presented at: Jefferies 2015 Global Healthcare Conference Agenda 1 Overview & Service Platforms 2 Adaptability, Scalability & Expansion Plans 3 Best Practices 4 Blue Chip Customer Base 5 Roadmap of Evolution

More information

Cytec Announces First Quarter 2010 Results. As-Adjusted EPS of $0.66, Significantly Above Prior Year As-Adjusted EPS of $0.06

Cytec Announces First Quarter 2010 Results. As-Adjusted EPS of $0.66, Significantly Above Prior Year As-Adjusted EPS of $0.06 cytec News & Information Cytec Industries Inc. Five Garret Mountain Plaza Woodland Park, New Jersey 07424 www.cytec.com Contact: Jodi Allen (Investor Relations) (973) 357-3283 Release Date: Immediate Cytec

More information

INVESTOR PRESENTATION

INVESTOR PRESENTATION INVESTOR PRESENTATION NASDAQ: PFSW 2014 PFSweb, Inc. www.pfsweb.com May 2014 CAUTIONS REGARDING FORWARD LOOKING STATEMENTS The matters discussed in this presentation, particularly information regarding

More information

ROFIN-SINAR REPORTS RESULTS FOR THE FIRST QUARTER OF FISCAL YEAR 2016

ROFIN-SINAR REPORTS RESULTS FOR THE FIRST QUARTER OF FISCAL YEAR 2016 - PRESS RELEASE - Contact: Katharina Manok ROFIN-SINAR 011-49-40-733-63-4256 - or - 734-416-0206 ROFIN-SINAR REPORTS RESULTS FOR THE FIRST QUARTER OF FISCAL YEAR 2016 Quarterly earnings per share increased

More information

China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year Fiscal 2010

China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year Fiscal 2010 China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year Fiscal 2010 Annual Revenue up 34.4% to RMB 261.5 Million Fiscal 2010 New Subscribers grew 30.5% Conference Call

More information

NAPCO Security Systems, Inc. NasdaqGS (Global Select): NSSC

NAPCO Security Systems, Inc. NasdaqGS (Global Select): NSSC NAPCO Security Systems, Inc. NasdaqGS (Global Select): NSSC Protecting People and Property Through Technology Investor Presentation May 2008 Safe Harbor Statement This presentation may contain forward-looking

More information